Colorectal cancer among farmers in the AGRICAN cohort study.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
06 2022
Historique:
received: 30 10 2021
revised: 24 02 2022
accepted: 27 02 2022
pubmed: 19 3 2022
medline: 25 5 2022
entrez: 18 3 2022
Statut: ppublish

Résumé

Specific farming types and tasks have rarely been studied in relation to colorectal cancer (CRC). We evaluated associations between 5 types of livestock and 13 types of crops in relation to CRC and its subsites within the Agriculture and Cancer (AGRICAN) study. AGRICAN cohort includes 181,842 agricultural workers living in 11 French geographical areas. Data on farming types and tasks was collected by self-administered questionnaires. We identified 2 609 CRC, 972 right colon, 689 left colon and 898 rectal incident cancer cases during follow-up from 2005 to 2015. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI). Significantly increased CRC risk was observed for farmers producing horses (HR=1.18, 95% CI 1.06-1.31), sunflower (HR=1.23, 95% CI 1.03-1.45) and field vegetables (HR=1.18, 95% CI 1.02-1.36). Positive associations were also observed for pig, poultry and wheat/barley. Some associations were observed only for specific subsites: left colon cancer was associated with fruit growing (HR=1.36, 95% CI 1.09-1.70) and potato (HR=1.28, 95% CI 1.05-1.57). Tasks related to livestock (animal care, insecticide treatment, disinfection of milking equipment and building) or to crop (haymaking, sowing, pesticide treatment, seed treatment, harvesting) were also associated with CRC. Duration and size of farming types/task increased the risk for some of the associations. Analysis stratified by sex suggested an interaction with several farming types/task. The current study showed original and positive findings for several farming types and tasks and CRC risk, overall and by subsites.

Identifiants

pubmed: 35303617
pii: S1877-7821(22)00030-3
doi: 10.1016/j.canep.2022.102125
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102125

Investigateurs

S Dabakuyo-Yonli (S)
S Bara (S)
A M Bouvier (AM)
T Busquet (T)
M Colonna (M)
G Coureau (G)
M Delanoé (M)
P Grosclaude (P)
A V Guizard (AV)
P Herbrecht (P)
J J Laplante (JJ)
B Lapotre-Ledoux (B)
G Launoy (G)
D Lenoir (D)
K Hammas (K)
E Marcotullio (E)
M Maynadié (M)
F Molinié (F)
A Monnereau (A)
A Paumier (A)
J Jarriges (J)
J M Thibaudier (JM)
X Troussard (X)
M Velten (M)
E Wavelet (E)
A S Woronoff (AS)

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Madar Talibov (M)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France. Electronic address: Mader.Talibov@gmail.com.

Séverine Tual (S)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Fabrice Morlais (F)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; University of Caen Normandy, Caen, France.

Matthieu Meryet-Figuière (M)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Mathilde Boulanger (M)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Véronique Bouvier (V)

Calvados Digestive Cancer Registry, France; Epidemiology Research and Evaluation Unit - UMR 1086 INSERM-UCN Anticipe, University Hospital of Caen, Avenue de la Côte de Nacre, 14033 Caen Cedex, France.

Stephanie Perrier (S)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France.

Bénédicte Clin (B)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; University of Caen Normandy, Caen, France; CHU de Caen, Service de Pathologie Professionnelle, Caen, France.

Isabelle Baldi (I)

EPICENE team, ISPED, INSERM U1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, France; CHU de Bordeaux, Service de Médecine du Travail et Pathologies Professionnelles, Bordeaux, France.

Pierre Lebailly (P)

Institut national de la santé et de la recherche médicale (INSERM), Unité mixte de recherche (UMR) 1086 ANTICIPE, Caen, France; Centre de Lutte Contre le Cancer François Baclesse, Caen, France; University of Caen Normandy, Caen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH